Companies › ENVB
Enveric Biosciences Inc (ENVB)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0000890821 · EDGAR filings · Updated 2026-06-09
Enveric Biosciences Inc (ENVB) has reported institutional ownership of 2.9%, with 11 institutional managers holding positions valued at $106.6K per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-06-09 — Current report (8-K) filed
- 2026-06-09 — Prospectus supplement (424B5) filed
- 2026-06-09 — Current report (8-K) filed
- 2026-06-03 — Insider transaction reported (Form 4)
- 2026-06-03 — Insider transaction reported (Form 4)
- 2026-06-03 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, Enveric Biosciences Inc has 11 institutional holders and institutional ownership of 2.9%.
Insider activity
Insiders reported 10 transactions (0 buys, 0 sells) across 8 reporting insiders, with a net reported value of $0.
Data flags from SEC filings
Related companies
Alzamend Neuro Inc (ALZN) · Bio Green Med Solution Inc (BGMS) · BLUEJAY DIAGNOSTICS INC (BJDX) · ORAGENICS INC (OGEN) · Glucotrack Inc (GCTK) · Catheter Precision Inc (VTAK)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-09.